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Abstract
Background: The increasing burden of cardiovascular diseases (CVD) in the ageing population of
industrialized nations requires an intensive search for means of reducing this epidemic. In order to
improve prevention, detection, therapy and prognosis of cardiovascular diseases on the population
level in Eastern Germany, it is necessary to examine reasons for the East-West gradient of CVD
morbidity and mortality, potential causal mechanisms and prognostic factors in the elderly.
Psychosocial and nutritional factors have previously been discussed as possible causes for the
unexplained part of the East-West gradient. A reduced heart rate variability appears to be
associated with cardiovascular disease as well as with psychosocial and other cardiovascular risk
factors and decreases with age. Nevertheless, there is a lack of population-based data to examine
the role of heart rate variability and its interaction with psychosocial and nutritional factors
regarding the effect on cardiovascular disease in the ageing population. There also is a paucity of
epidemiological data describing the health situation in Eastern Germany. Therefore, we conduct a
population-based study to examine the distribution of CVD, heart rate variability and CVD risk
factors and their associations in an elderly East German population. This paper describes the design
and objectives of the CARLA Study.
Methods/design: For this study, a random sample of 45–80 year-old inhabitants of the city of
Halle (Saale) in Eastern Germany was drawn from the population registry. By the end of the
baseline examination (2002–2005), 1750 study participants will have been examined. A multi-step
recruitment strategy aims at achieving a 70 % response rate.
Detailed information is collected on own and family medical history, socioeconomic, psychosocial,
behavioural and biomedical factors. Medical examinations include anthropometric measures, blood
pressure of arm and ankle, a 10-second and a 20-minute electrocardiogram, a general physical
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BMC Cardiovascular Disorders 2005, 5:33 http://www.biomedcentral.com/1471-2261/5/33examination, an echocardiogram, and laboratory analyses of venous blood samples. On 200
participants, a 24-hour electrocardiogram is recorded. A detailed system of quality control ensures
high data quality. A follow-up examination is planned.
Discussion: This study will help to elucidate pathways to CVD involving autonomic dysfunction
and lifestyle factors which might be responsible for the CVD epidemic in some populations.
Background
Cardiovascular diseases (CVD) are the leading cause of
death and morbidity in industrialized nations, accounting
for about 50% of all deaths [1]. In old age, both incidence
and prevalence of CVD are increasing. Although the mor-
tality of coronary heart disease has decreased since the
1970s, the prevalence, incidence and mortality of chronic
heart failure has persisted or even increased [2-5]. In the
ageing population, chronic heart failure (CHF) is an
increasing public health problem and poses a mounting
economic burden on societies and their health care sys-
tems due to its association with frequent hospitalizations
and the need for long-term pharmacological treatment
[2,6-9].
Moreover, in spite of the general decline of cardiovascular
mortality over the past decades, an increasing East-West
gradient within Europe has been observed with decreasing
life-expectancy and higher rates of cardiovascular morbid-
ity and mortality in Eastern European countries which
seems to arise from premature CVD [10,11]. This discrep-
ancy has grown since the political changes and socioeco-
nomic discontinuities in Eastern Europe at the beginning
of the 1990s and cannot be explained entirely by the clas-
sical risk factors for cardiovascular diseases alone [12].
Even within Germany, an East-West gradient of CVD mor-
tality is still present after re-unification [13]. However,
there is a lack of population-based data on CVD morbid-
ity and risk factors to further analyse the extent, cause and
potential for reduction of the increased CVD burden in
the East. Among the newer risk factors discussed as poten-
tial explanations for the East-West gradient are nutritional
factors, alcohol and psychosocial factors [10,14,15]. Psy-
chosocial factors such as depression, social isolation, job
strain and hostility are associated with higher CVD risk
[16-19] and are differentially distributed by socioeco-
nomic status [20-23].
Autonomic dysfunction as indicated by a reduced heart
rate variability (HRV) is increasing with age [24,25] and
has been observed to be associated with an increased risk
for incident coronary heart disease (CHD), CVD mortality
[26-30] and worse prognosis in patients with CHD or
heart failure [31-34]. However, there is growing evidence
that adverse psychosocial factors might also be associated
with a reduced HRV and other measures of sympathova-
gal imbalance [35-38]. A reduced heart rate variability
appears to integrate negative factors such as disease and
stress. Thus, autonomic dysfunction, of which HRV is a
marker, might play an important role in mediating the
effect of social inequality, psychosocial factors and other
cardiovascular risk factors on CVD causation and progno-
sis [39-42].
For inflammatory factors such as C-reactive protein (CRP)
and cytokines (tumour necrosis factors, interleukin-6),
higher levels have been observed in elderly subjects and in
subjects at higher risk of chronic heart failure (CHF)
[43,44]. They have also been associated with a reduced
HRV [45]. However, the role of inflammatory factors and
their interaction with HRV in the pathogenesis of heart
failure is still not well understood. There is a lack of pop-
ulation-based studies to investigate the potential mecha-
nisms involving HRV, inflammatory factors and
psychosocial factors underlying causation and prognosis
of CHF.
The examination of heart rate variability in a general pop-
ulation might provide valuable information to elucidate
some of the pathways relevant for the development and
prognosis of CVD. It might also help to explain the mech-
anisms underlying the observed associations of psychoso-
cial factors with CVD. Moreover, unfavourable
psychosocial factors and a reduced heart rate variability
could be among the factors responsible for the higher
CVD mortality in Eastern European and Eastern German
populations as compared to their Western counterparts.
The examination of reasons for regional variation such as
the East-West gradient of CVD morbidity and mortality as
well as of potential mechanisms of causation and of prog-
nostic factors in the elderly could lead to advances in the
prevention, detection, therapy and prognosis of cardio-
vascular diseases on the population level.
Furthermore, the role of HRV as a potential additional
screening tool for the identification of subjects at high risk
of acquiring cardiovascular diseases or of suffering fatal
adverse events should be explored. However, there is a
lack of population-based data regarding the distribution
of HRV and its interaction with other CVD risk factors in
the general ageing population. The recording of 24-hour
holter electrocardiograms (ECG) or ECGs of at least 2
hours duration is still the recommended standard for HRV
analysis in clinical practice [46]. While 24-hour ECGsPage 2 of 14
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tuations in daily activities and thus contain other infor-
mation than short-term ECGs, a great advantage of short
ECG recordings in resting state is that they can be highly
standardized and are easier to apply in larger populations.
For screening purposes in a general population, the
recording of long-term ECGs is impractical.
Although short-term and long-term ECGs measure differ-
ent components of HRV, one study in healthy young men
showed a high predictive value of short-term ECGs for
long-term ECGs [47]. Unfortunately, there is a lack of
studies assessing the validity and predictive value of short-
term ECGs for the determination of HRV as compared to
HRV measures derived from 24-hour ECGs in the general,
elderly population. Therefore, it is important to examine
whether ECGs of shorter recording duration (e. g., 20
minutes) are a valid basis for the identification of subjects
with reduced HRV in the general population.
This paper presents the design and objectives of the CAR-
diovascular disease, Living and Ageing in Halle (CARLA)
Study.
The aims of this study are:
1. to examine the distribution of different parameters of
heart rate variability and the prevalence of a reduced HRV
in a representative sample of an elderly East German pop-
ulation;
2. to examine the prevalence of cardiovascular diseases
and their association with HRV, psychosocial and socioe-
conomic factors, and inflammatory and classical cardio-
vascular risk factors in an ageing general population;
3. to identify factors responsible for the epidemic of
chronic heart failure in the ageing population, and to
identify potential areas of prevention;
4. to elucidate reasons for regional variations in CVD mor-
bidity and mortality; and
5. to assess the potential of HRV derived from short-term
ECGs as a screening tool in the general population for the
detection of subjects at high risk of CHD or CHF and for
risk stratification in chronic heart failure or other cardio-
vascular diseases.
A planned follow-up study will allow the determination
of incident events.
Methods/design
The design of the CARLA study is a population-based epi-
demiologic cross-sectional study with the aim of a pro-
spective follow-up of the examined study subjects, thus
leading to a cohort study. The study was approved by the
Ethics Committee of the Medical Faculty of the Martin-
Luther-University Halle-Wittenberg and by the State Data
Privacy Commissioner of Saxony-Anhalt. The study is
conducted by the Institute of Medical Epidemiology,
Biostatistics and Informatics in cooperation with the
Department of Internal Medicine III (Cardiology, Angiol-
ogy and Medical Intensive Care) at the Martin-Luther-
University Halle-Wittenberg.
Study population, sampling and recruitment procedure
The base population for the study participants are male
and female inhabitants of German nationality of the city
of Halle (Saale) in Saxony-Anhalt, Eastern Germany, aged
45 to 80 years. The city of Halle has approximately 240
000 inhabitants and is the largest city in Saxony-Anhalt. A
random sample of 5000 men and women aged 45 to 80
years at the time of the sampling (July 2002) was drawn
from the population registry of the city of Halle.
The sampling was done within the age strata 45–49, 50–
54, 55–59, 60–64, 65–69, 70–74 and 75–80 years. In all
but the last stratum, equal numbers of men and women
were drawn (322 women and 323 men per stratum). The
age stratum 75–80 years was oversampled with twice as
many inhabitants drawn into this sample than for each of
the other strata (625 women and 625 men). This was
done in order to account for lower expected response rates
in the oldest group.
The recruitment of study subjects began in December
2002 and is aimed to be completed by the end of the year
2005. When completed, the final study population will
comprise 1750 persons. Up to July 2005, about 1500 sub-
jects were examined. Assuming comparable response rates
within all age-sex strata except the oldest one, we expect to
recruit about 120 men and 120 women in each 5-year-age
group from 45 to 74 years, and 155 men and women each
in the age-group 75 to 80 years. An overall response rate
of 70 % is aimed at.
The recruitment of study subjects has been done by invit-
ing consecutive waves of random sub-samples of the orig-
inal population sample. Therefore, not all persons
originally drawn from the population registry have to be
invited in order to obtain a representative sample of the
Halle population aged 45 to 80 years.
The method of recruitment applied in the CARLA study
was selected after discussion with experts about the most
efficient strategies to achieve the desired response rate.
The recruitment strategy includes at least two written invi-
tations and active contact attempts by the study personnel
via telephone or home visit if the eligible person does notPage 3 of 14
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contains a letter of invitation, a detailed description of the
aims and examination procedures of the study, and a copy
of the approval letter of the Data Privacy Commissioner
for Saxony-Anhalt. Different recruitment strategies are fol-
lowed for subjects for whom a home telephone number
Recruitment scheme for CARLA baseline examinationFigure 1
Recruitment scheme for CARLA baseline examination.
Random sample of
45-80 year old inhabitants of Halle
Known telephone-no. Unknown telephone-no.
1st written invitation
Phone contact
10x at different times and days
Subject refused
to participate
Participation by subject
Target: 1750 subjects
If no active response
No response 
from subject
1st written invitation
2nd written invitation
2nd written invitation
Home visitHome visit
If not successful within 6 weeks
If no response or contact
If no active response
If no active response
Subject excluded
by investigatorPage 4 of 14
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and for those with an ex-directory or no telephone
number:
Persons with known telephone numbers are identified
and receive a letter of invitation announcing a subsequent
phone call by the study personnel. If the person does not
respond actively to the invitation letter, study personnel
make at least 10 attempts to establish telephone contact at
different times of the day and on different days. If no con-
tact can be made over at least six weeks, a reminder invi-
tation is mailed to the subject, offering the option of
replying with a prepared reply-paid card indicating con-
venient examination dates. If the second invitation does
not lead to a contact with the subject or to verification of
his response state (e. g. moved with unknown address, too
ill to participate in the study, deceased, or unwilling to
participate in the study), a home visit is performed by
study personnel. Several attempts are made to localize the
study subject or to retrieve information from relatives or
neighbours regarding the subject's correct address of resi-
dence or telephone number, or their willingness or ability
to participate.
For those subjects without a registered telephone number,
two invitation letters with reply-paid cards are sent before
entering the home visit phase.
All direct contact attempts (phone or home visit) are
made by trained and certified study personnel and are
documented in detail. At each home visit which does not
result in contact with the invited subject or another mem-
ber of the household, the home visitor leaves a pre-
printed note indicating that a visit has been made and
indicating how contact can be made with the researchers.
Figure 1 shows the recruitment scheme of the CARLA
Study.
A letter confirming the date of examination is sent to sub-
jects who agreed to participate in the study and contains a
Table 1: Components and sources of the interview used in the baseline survey of the CARLA Study
Topics of interview module Source (reference, original study)
Sociodemographic factors:
1. Subject's own education, occupational status, net household income
2. Parental education and occupational status
3. Partner's education and occupational status
1. Demographic standards for Germany [81]
2. adapted according to [81]
3. adapted according to [81]
Utilization of medical services Modified from SHIP [49,82]
Chronic diseases: own medical history
1. cardiovascular diseases: coronary heart disease, stroke, hypertension
2. chest pain
3. intermittent claudication
4. hypercholesterolemia
5. diabetes
6. thyroid disease
7. osteoporosis
8. rheumatoid arthritis
9. chronic diseases
10. cancer
Chronic diseases: family history
1. myocardial infarction, stroke, hypertension
2. diabetes
3. cancer
Menopausal state and use of hormone replacement therapy
All adopted from SHIP [49,82] and KORA/MONICA [48,83-85];
Rose questionnaire for chest pain and intermittent claudication [54]
Medication use during the preceding 7 days IDOM software developed by GSF, based on the GKV medication 
database for Germany, used in KORA study [55,56]
Health related behaviour/lifestyle factors
1. diet/nutritional habits – short qualitative food frequency list
2. alcohol use
3. physical activity
4. smoking
1. adopted from KORA/MONICA [83,86]
2. adopted from HAPIEE [52]
3. Baecke questionnaire [87], also used in SHIP and ARIC
4. adapted and shortened from smoking questionnaire developed by W. 
Ahrens, BIPS
Social support Modified version of Berkman-questionnaire (translation by J. Siegrist 
used in KORA/MONICA) [48,84,88,89]
Unemployment, job insecurity Adopted from SHIP [49,82] and HAPIEE [52]
Material circumstances Adopted from HAPIEE [52]
ARIC = Atherosclerosis Risk in Communities; BIPS = Bremen Institute for Prevention Research and Social Medicine; CES-D = Center of 
Epidemiological Studies Depression Scale; EPIC = European Prospective Investigation into Cancer and Nutrition; HAPIEE = Health, Alcohol and 
Psychosocial Factors in Eastern Europe; KORA = Cooperative Health Research in the Augsburg Region; MONICA = Monitoring Trends and 
Determinants in Cardiovascular Disease; SF 12 = Short Form Health Survey Questionnaire; SHIP = Study of Health in PomeraniaPage 5 of 14
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istered questionnaire.
Data collection – interview, questionnaires and 
examination procedures
In order to provide a basis for pooled data analyses and to
permit valid comparisons with other study regions and
populations, the CARLA Study deliberately uses highly
standardized and validated instruments of data collection
which have been applied in several completed or ongoing
national and international cardiovascular disease epide-
miologic studies. Questionnaire items and examination
procedures were selected and adapted from i.) the KORA
Study Augsburg in Bavaria, Southern Germany (the con-
tinuation of the MONICA Surveys in Augsburg) [48]; ii.)
the SHIP Study Greifswald in Pomerania, North-Eastern
Germany [49]; iii.) the EPIC Potsdam Study, Eastern Ger-
many [50]; iv.) the Rotterdam Study, The Netherlands
[51]; and v.) the HAPIEE Study which includes study
regions in the Czech Republic, Poland, Russia and Lithua-
nia [52].
After selection of interview items and examination proce-
dures, a pretest was performed to test instruments and
logistics of data collection. Slight modifications were
made before recruitment of the study subjects started.
The data collection consists of a standardized, computer-
assisted personal face-to-face interview, a self-adminis-
tered questionnaire, a medical examination by a trained
and certified study nurse, and a physical examination and
a transthoracic echocardiogram performed by a physician
who has been specifically certified for this study. The
examination takes place at the CARLA study centre in the
University Hospital of the Martin-Luther-University
Halle-Wittenberg. The average duration is 3.5 hours per
subject.
Interview
The computer-assisted interview was programmed with
the DAIMON interview programme which was also used
in the KORA 2000 Survey Augsburg [53]. The interview
collects information on sociodemographic and socioeco-
nomic data, medical history and cardiovascular risk fac-
tors. In detail, it includes questions on household income,
educational level and occupation of the interviewee, and
his or her parents and partner (where appropriate), mate-
rial circumstances, psychosocial factors such as social sup-
port, unemployment and job security, changes in
socioeconomic factors and social relations since the Ger-
man re-unification in 1990, utilization of health care serv-
ices, family medical history of chronic diseases, and
history of any physician-diagnosed cardiovascular dis-
eases (coronary heart disease, stroke, arterial hyperten-
sion), diabetes, hypercholesterolemia, thyroid disease,
osteoporosis, chronic bronchitis, rheumatoid arthritis
and cancer. It furthermore contains the Rose question-
naire on angina pectoris and intermittent claudication
[54] and information on lifestyle-factors such as smoking,
diet, alcohol consumption and physical activity. The
interview lasts approximately one hour. Details of the
sources of the interview modules are listed in table 1.
Information on the use of medication during the seven
days preceding the examination is collected by the study
nurse with the computer-based IDOM programme [55]. It
integrates the GKV medication database, the official med-
ication database of the Wissenschaftliches Institut der Ort-
skrankenkassen (WIdO, Scientific Institute of the Local
Sickness Funds) which is continuously updated and
allows an automated search for individual drugs by PZN
number (central pharmanumber) and direct retrieval of
ATC codes [56].
Self-administered questionnaire
The self-administered questionnaire contains the food-
frequency questionnaire (FFQ) also used in the EPIC Pots-
Table 2: Components and sources of the self-administered questionnaire used in the baseline survey of the CARLA Study
Topics of questionnaire modules Source (reference, original study)
Health related behaviour/lifestyle factors
1. diet/nutritional habits – quantitative food frequency questionnaire 
(FFQ)
2. alcohol use – binge drinking
1. adopted from EPIC [50]
2. adopted from HAPIEE [52]
Social networks Modified version of Berkman-questionnaire (translation by J. Siegrist 
used in KORA/MONICA) [48,84,88,89]
Perceived security in neighbourhood environments before and after 
German re-unification in 1990
adopted and translated from HAPIEE [52,90-92]; similar questions in 
SHIP [82]
Health beliefs Adopted from HAPIEE [52]
Health-related quality of life Social functioning questionnaire SF 12 [93]
Job strain, effort-reward imbalance Effort-reward imbalance questionnaire by J. Siegrist [57,58]
Depression scale German translation of the CES-D depression scale by Kohlmann & 
Gerbershagen [94-96]
Abbreviations: same as in table 1Page 6 of 14
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alcohol drinking patterns aimed at obtaining information
on binge drinking, questions about health beliefs, social
networks, the CES-D questionnaire on depression, the SF-
12 questionnaire on self-rated health and health-related
quality of life, the effort-reward imbalance questionnaire
developed by Siegrist [57,58], and questions about secu-
rity in the neighbourhood environment before and after
the re-unification in 1990. The EPIC FFQ is usually com-
pleted at home after the examination date and sent back
via reply-paid envelope.
Details on the sources of the questionnaire modules are
listed in table 2.
Examination procedures
The medical examination includes the measurement of
anthropometric parameters and arterial blood pressure,
the determination of the ankle-arm index of systolic
blood pressure, the recording of a 10-second- and a 20-
minute electrocardiogram, a trans-thoracic echocardio-
gram, and the drawing of a venous blood sample.
At the beginning of the examination, the subject is seated
comfortably in a chair and asked to assume the position
required later for the correct measurement of sitting blood
pressure. Then, the medication currently taken by the
study subject is recorded using the IDOM programme (see
table 1). After a resting period of at least five minutes, the
measurement of systolic and diastolic blood pressure is
started. Blood pressure is measured with the OMRON
HEM-705CP automated oscillometric blood pressure
device [59] according to the procedure employed in the
SHIP and KORA/MONICA Study [48,49,55]. The
OMRON HEM-705CP device meets the criteria defined
for the use in clinical trials by the Association for the
Advancement of Medical Instrumentation and the British
Hypertension Society. The size of the cuff is selected
according to the arm circumference (circumference <32
cm: normal adult cuff, circumference 32 – <42 cm: large
adult cuff). Three measurements are performed on the left
arm with a three-minute delay between each pair of meas-
urements. Heart rate is counted manually during the rest-
ing period. Data entry of the measurements is done
immediately using the DAIMON screen developed by the
GSF which includes a timer for the three-minute delay
between the blood pressure measurements [53].
The anthropometric measurements follow the procedures
used in the MONICA/KORA and SHIP study [48,49,55].
Weight and height are measured with the SECA 701 dig-
ital scale and the SECA 220 height measuring system.
Waist and hip circumference are measured using a flexible
tape, with the study subject standing in front of a full-size
mirror which allows checking the horizontal position of
the tape. Weight is recorded with a precision of 100 g, and
height, waist and hip circumference to the nearest 0.1 cm.
The individual is then asked to lie down and rest for at
least five minutes before the measurement of supine
systolic blood pressure at arm and ankle is commenced
for the determination of the ankle-arm index as indicator
of peripheral arterial disease (PAD). The protocol for the
measurement of ankle-arm index using the OMRON
HEM-705CP both at arm and leg was developed by the
CARLA Study. First, a simultaneous measurement of
blood pressure (BP) at both arms is performed. For the BP
measurements used for the calculation of ankle-arm
index, the OMRON HEM-705CP device remains on the
arm with the higher systolic blood pressure. The circum-
ference of both calves is determined at the midpoint of the
BP cuff to select the adequate cuff size. The cuff is posi-
tioned approximately 5 cm above the inner ankle over the
posterior tibial artery in contour wrap technique [60].
Measurement of BP is started simultaneously on arm and
ankle, using two OMRON HEM-705CP devices at the
same time. First, two measurements are performed at the
right ankle, followed by two measurements at the left
ankle. Between each pair of measurements, there is a one-
minute delay.
Following the supine BP measurement two resting electro-
cardiograms (ECG) are recorded: one 10-second and one
20-minute 12-lead ECG. The study subject remains in
supine position and is not allowed to raise from the
beginning of the supine BP measurements until comple-
tion of the ECGs. The attachment of the electrodes follows
the standard procedures for measuring and marking of the
electrode positions using a DAL-square as described in the
ARIC Manual 5 Electrocardiography [61] and adopted by
the KORA/MONICA Study [55]. The ECGs are recorded
using a Cardio Control Medical Diagnostic Workstation
1.3.1 with a Cardio Perfect MD Recorder with a sampling
rate of 600 Hz (Welch Allyn Cardio Control, Delft, NL)
and stored digitally. The study subject is asked to remain
in supine position and not to speak throughout the ECG
recording. The 10-second ECG is recorded first, and a
printout is provided for interpretation by the study physi-
cian.
It is required that the study subject has remained in supine
resting position for at least 20 minutes before the record-
ing of the 20-minute ECG is started. The baroreceptors
which sense the blood pressure in the aorta and in the
carotid sinuses are instrumental in the genesis of HRV.
The 20-minute supine resting period ensures that the
baroreceptors have adapted to the change in blood pres-
sure due to assuming the supine position. Throughout the
20-minute ECG, the subject is asked to breathe at a fre-
quency of 15/min (0.25 Hz). For guidance of the exact res-Page 7 of 14
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Metronome, a visual metronome developed by H. v. d.
Vooren and M. Santunione (©Leiden University Medical
Center, Cardiology Department, used with permission by
C. A. Swenne) is displayed on a computer screen easily vis-
ible for the subject. The purpose of the metronome guided
respiration is to standardize the ECG recording as much as
possible with respect to the influence of the respiratory
rate on the determination of spectral parameters of the
HRV. Thus, by ensuring a standard supine resting period
of 20 minutes preceding the ECG recording and an equal
respiratory rate for all subjects, the major physiological
mechanisms influencing short term HRV are controlled
for, and any differences in HRV found between subjects or
groups of subjects can be attributed to other factors that
are characteristic to the study subject (e. g. pathological
processes, or influence of other risk factors on HRV).
After the ECG recording, a non-fasting venous blood sam-
ple is drawn under standardized conditions according to
the KORA/MONICA protocol [48,55,62] with the subject
remaining supine.
A transthoracic echocardiogram is performed on the GE
Vingmed Ultrasound Vivid Five System or on the GE
Vingmed System Five Performance with a FPA 2.5 MHz
probe and Echo Pac Software version 6.3 (GE Medical Sys-
tems Ultrasound, GE Ultraschall Deutschland, Solingen)
by a certified study physician following the protocol of the
SHIP Study [49,63]. It collects information on parameters
derived from M-Mode and Doppler standard echocardio-
graphic techniques. Parameters to be studied include
measurements required for the determination of left ven-
tricular mass and systolic and diastolic function. Images
and measurements of the echocardiographic examination
are saved on optical disc and video to permit offline read-
ing. The examination is concluded with an explication of
the immediately available examination results (e. g., ele-
vated blood pressure values, major electrocardiographic
or echocardiographic abnormalities) for the study subject
by the study physician. Table 3 gives an overview of the
examination components and equipment.
For a random sub-sample of 200 subjects, a 24-hour ECG
is recorded with the DMS 300-9 holter ECG recording sys-
tem with a sampling rate of 1024 Hz (mtm Multitechmed,
Hünfelden, Germany).
Laboratory analyses
The non-fasting venous blood samples include the collec-
tion of serum, EDTA plasma, citrate plasma and EDTA full
blood. All serum and plasma samples are centrifuged at
4°C in-house by specially trained study laboratory per-
sonnel. A small part of the serum and EDTA plasma is sent
for analysis of total, HDL and LDL cholesterol, triglycer-
ides, glucose, haemoglobin A1c (HbA1c), creatinine,
high-sensitive C-reactive Protein (CRP) and n-terminal
brain natriuretic peptide (NT-proBNP) to a single central
laboratory at the University of Leipzig. All laboratory anal-
yses – except for the determination of cytokines – are
undertaken by the Institute of Laboratory Medicine, Clin-
ical Chemistry and Molecular Diagnostics (ILM) at the
Leipzig University Clinics. The laboratory has been
accredited according to the accreditation norms ISO
15180 and ISO 17025. The cytokines interleukin-1 and 6
(IL-1, IL-6) and tumour necrosis factor-alpha (TNF-α) are
determined at the research laboratory of the Department
of Medicine III at the Martin-Luther-University Halle-Wit-
tenberg. The major part of the specimens is stored at -
80°C for future analysis. Citrate plasma is stabilized with
10% metaphosphoric acid (0.1 ml plasma : 0.9 ml MPA)
before freezing for subsequent analyses of ascorbic acid
(vitamine C). Serum total cholesterol is analyzed with the
enzymatic colorimetric CHOD-PAP method at the Modu-
lar system (Roche Diagnostics, Mannheim, Germany)
[64]. A homogenous enzymatic colorimetric test is used
for the determination of serum HDL and LDL cholesterol
at the Modular system [64,65]. Serum triglycerides are
measured applying the colorimetric enzymatic GPO-PAP
assay at the Modular system [64]. Casual serum glucose is
Table 3: Examination components and equipment of the CARLA Study
Examination components Parameters Instruments
Anthropometry Body weight, body height, waist- and hip 
circumference, body mass index
Digital scales (SECA 701), body height 
measuring system (SECA 220), tape measure
Blood pressure Systolic and diastolic blood pressure at the arm 
and the ankle, heart rate
OMRON HEM-705CP automated oscillometric 
blood pressure measurement device
Electrocardiogram Minnesota-Code (MEANS), HRV parameters, 
general de- and repolarisation parameters in 
the ECG (LEADS)
1. Welch Allyn Cardio Control Diagnostic 
Medical Workstation, MD Recorder, 600 Hz 
sampling rate (10-sec/20-min ECG)
2. mtm Multitechmed DMS 300-9 holter ECG 
recorder, 1024 Hz sampling rate
Echocardiogram Measures of systolic and diastolic function, 
heart valves, ventricular dimensions
GE Vivid Five/System Five with FPA 2.5 MHz 
probePage 8 of 14
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method. For the analysis of HbA1c in EDTA anticoagu-
lated blood, the High Performance Liquid Chromatogra-
phy (HPLC) method is used with the Variant II system
(BIO-RAD, Munich, Germany). Creatinine is measured
colorimetrically enzymatically on the Modular system
[64]. High-sensitive C-reactive proteine (hsCRP) is deter-
mined with a turbidimetric immunologic reaction assay
enhanced by the addition of latex on the Modular system
[64,66]. NT-proBNP is measured using an electro-chemo-
illuminescence assay by Roche Diagnostics on the Elecsys
system (Roche Diagnostics, Mannheim, Germany)
[67,68]. IL-1, IL-6 and TNF-α are measured using ELISA-
techniques.
Genetic analyses including the haplotype mapping of spe-
cific gene variants (SNPs) using a pathway-oriented
approach are planned. SNPs of the following signal and
metabolic paths important for ageing will be analysed
using blood stored at -80°C: 1.) the TNF-α/NF-κB path-
way relevant for inflammatory factors and immune senes-
cence; 2.) the IGF-1/PI3K/Akt longevity pathway; 3.)
candidate genes for ageing (RAGE, ApoE, Klotho, inter-
leukin-6 promotor polymorphism). Genes showing a
positive association with a reduced HRV or a reduced car-
diac function indicating cardiac ageing will be examined
regarding their specific function and regulation in the
context of cardiac ageing.
For a random subsample of 400 subjects, further labora-
tory parameters from frozen samples will be analysed, e.
g. lipoprotein (a), vitamins, folic acid, homocysteine and
thyroid hormones.
ECG analyses
All 10-second ECGs are processed by the Modular ECG
Analysis System (MEANS) [69] to obtain Minnesota
Codes [70]. The MEANS program has been extensively
validated [69,71-73]. MEANS also processes the 20-
minute ECGs to obtain the locations and types of the QRS
complexes. This information is then used to analyse HRV
computing standard time domain and frequency domain
parameters of HRV. HRV is computed according to the
procedure used in previous studies. The method has been
described elsewhere [47,74,75]. Briefly, artefacts and
ectopic beats are replaced by interpolated normal sinus
beats to a maximum of ten percent. For each ECG, the per-
centage of replaced beats is calculated. ECGs which dis-
play non-sinus rhythm, like atrial fibrillation, or where
the majority of QRS complexes is paced by an artificial
pacemaker, are excluded from HRV analysis.
Then, time domain parameters of HRV are calculated. The
calculated time domain HRV parameters include the
standard deviation of normal intervals (SDNN), the mean
absolute successive normal interval differences, the root
mean square successive normal interval differences
(rMSSD), and the percentage of successive normal interval
differences >50 ms (pNN50).
Prior to spectral analysis of the ECG, the tachogram has to
undergo further processing steps. The further pre-analytic
treatment of the inter-beat-interval (IBI) tachogram,
which is the graphical presentation of RR intervals over
time, includes an adjustment for linear trends, tachogram
tapering and zero padding. A test of stationarity is per-
formed, and non-stationary recordings are excluded from
analysis. ECGs with extreme HRV values or high in-sta-
tionarity scores are visually checked to identify possible
sources of error or explanations for the extreme values. If
only part of the ECG is responsible for the lack of overall
stationarity, stationary sub-sections of the 20-minute ECG
are identified and selected for repeated HRV analysis.
For spectral density estimation of frequency domain vari-
ables, a fast Fourier transformation is employed to calcu-
late very low frequency power (VLF power), low frequency
power (LF power), high frequency power (HF power) and
total power (TP).
Those HRV parameters are also calculated from 24-hr
ECGs. The ranking of the subject regarding the distribu-
tion of HRV parameters in the study population and the
diagnosis of a reduced HRV are compared between results
derived from 20-minute ECGs and from 24-hour ECGs.
The addition of further ECG parameters – such as param-
eters describing T-wave complexity [76], the ventricular
gradient, and the spatial angle between the QRS and T
axes [77] – characterizing relevant physiological and
pathophysiological processes which might improve the
understanding of cardiovascular disease mechanisms –
have been incorporated into the MEANS programme (MI-
EUR) and into the LEADS programme (LUMC) [78] and
are available for future analysis.
Echocardiographic analyses
The transthoracic echocardiographic examinations are
stored as digital files in order to permit off-line reading of
the parameters independent of the examination proce-
dure itself. However, for immediate documentation and
interpretation by the study physician, online reading is
performed during the examination. The analysis includes
parameters of left ventricular dimension (left ventricular
mass) and of systolic and diastolic function derived from
M-Mode and Doppler echocardiographic measurements.Page 9 of 14
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personnel and data quality management
In order to ensure a highly standardized data collection,
all study personnel is specifically trained and certified for
the study procedures. Interviewers and the study nurse
were trained and certified in cooperation with the KORA
study centre Augsburg before commencement of data col-
lection in the study. Apart from certification examina-
tions, a high level of standardization and examination
quality is ensured by repeated supervisions of the study
nurse and interviewers (by the principal investigator) dur-
ing the examination or interview of study subjects.
For means of quality control, all interviews are digitally
recorded, and a randomly selected sample of 10% of all
interview recordings is monitored by comparing audiore-
cording with the data entry. In addition, interviews found
to contain implausible answers during the computerized
plausibility checks are monitored using the audiorecord-
ing.
The CARLA study physicians participate in the observer
and reader certification for the echocardiographic exami-
nation held at the SHIP study centre Greifswald for
echocardiographers of the SHIP and KORA study.
All paper documentation is double entered in order to
minimize errors due to data entry. Visual and computer-
ized plausibility checks are performed to detect possible
data entry errors of paper documentation, examination
procedures or interview. (The plausibility checks applied
to ECG data have been described briefly above.)
Statistical analysis
The statistical analysis includes the calculation of fre-
quency distributions including means and medians of risk
factors and HRV parameters by age, sex and cardiovascular
disease status, the calculation of the prevalence of adverse
risk factor levels and cardiovascular diseases, the calcula-
tion of correlation coefficients, and linear and logistic
regression analyses. Differences between groups are tested
using the t-test, the F-test or a test for trend. Standard
errors, standard deviations and 95% confidence intervals
are calculated to evaluate precision of the estimates. All
statistical analyses are performed with SAS, Version 9 (SAS
Institutes, Cary, NC). To assess validity of the 20-minute
ECG compared to the gold standard (24-hour ECG),
standard measures for diagnostic tests (sensitivity, specif-
icity, positive and negative predictive value) are calcu-
lated.
Sample size calculation
The sample size calculation was performed according to
the primary outcome "Occurrence of reduced heart rate
variability (RHRV)". This is to be estimated among sub-
jects free from cardiac disease. We assumed that those
make up about 50% in all age-sex strata. Assuming a true
RHRV of 10%, a two-sided 95% confidence interval for
this prevalence will have a one-sided length of 5.6%
[4.4%; 15.6%] with 110 subjects free form cardiac disease.
As such, a total of 220 subjects per 10-year-age-sex-stra-
tum will be included, and a total sample size of 1760 sub-
jects is needed for eight strata.
Discussion
In the ageing populations of industrialized nations, the
increasing burden of chronic cardiovascular diseases
already has an enormous impact on population health,
the health care system and the economy. The need for a
better understanding of how to achieve "healthy ageing",
how to slow down the processes of cardiovascular disease
generation and progression, and how to improve preven-
tive and therapeutic strategies is obvious in societies with
a steadily rising life expectancy. But a better understand-
ing of the disease processes is also essential for the reversal
of the deleterious effect of the political and economic dis-
ruptions in Eastern Europe since the late 1980s on the
population health with sharply increasing mortality and
decreasing life expectancy. There is increasing evidence for
an important contribution of the dysbalance of the auto-
nomic nervous system with predominance of the sympa-
thetic system to disease processes. There are conflicting
results regarding a possible mediating role of autonomic
dysfunction on the pathway from socioeconomic and psy-
chosocial risk factors to cardiovascular disease, but popu-
lation-based data on HRV are scarce [39-42,79,80].
The CARLA study aims to create a database for a detailed
analysis of the association of markers of autonomic dys-
function with other cardiovascular risk factors on the path
to cardiovascular disease. The wide age range of the
present study population, being representative of a gen-
eral population, permits the analysis of age-dependent
effects and of processes which become more important at
older age. Due to the selection of standardized examina-
tion procedures and interview items applied in other
regional studies, this study serves for comparative analy-
ses which might increase the chance to discover pathways
responsible for the CVD epidemic in some populations.
The recording of 20-minute ECGs in a large sample of the
elderly general population gives the unique opportunity
to examine markers of autonomic dysfunction with a
higher precision than the shorter ECGs recorded in most
other population-based studies to date. The additional
comparison with 24-hour ECGs in the same study popu-
lation increases the diagnostic security of the short-term
ECGs. The study of further parameters of ECG physiology
could create a deeper understanding of pathophysiologic
processes responsible for the development and progres-
sion of cardiovascular diseases. This is a prerequisite ofPage 10 of 14
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populations with a growing percentage of elderly persons
with naturally high disease rates or in populations with
increased numbers of premature cardiovascular disease.
Conclusion
With the analysis of potential pathways from established
and newer cardiovascular risk factors to cardiovascular
disease, the CARLA study contributes important informa-
tion needed for a successful change towards healthier age-
ing which can only be achieved by strengthening
prevention as well as improving detection and supporting
therapeutic steps in the management of cardiovascular
diseases.
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